Nat Wilganowski

Statistics

Publications

Citations

486

H-Index

Active since

2007

Affiliations

Lexicon Pharmaceuticals (United States)(Current)

Nat Wilganowski is an author at Lexicon Pharmaceuticals (United States) specializing in life sciences, lipid biochemistry, and lipoprotein lipase-mediated lipolysis.

Publications per year

2007–2009

Publications

Lipid-lowering effects of anti-angiopoietin-like 4 antibody recapitulate the lipid phenotype found in angiopoietin-like 4 knockout mice

Urvi Desai, E-Chiang Lee, Kyu Hyuck Chung et al. · Proceedings of the National Academy of Sciences · 2007 · 196 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Identification of a New Functional Domain in Angiopoietin-like 3 (ANGPTL3) and Angiopoietin-like 4 (ANGPTL4) Involved in Binding and Inhibition of Lipoprotein Lipase (LPL)

E-Chiang Lee, Urvi Desai, Gennady Gololobov et al. · Journal of Biological Chemistry · 2009 · 165 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +15

GPIHBP1 stabilizes lipoprotein lipase and prevents its inhibition by angiopoietin-like 3 and angiopoietin-like 4

William K. Sonnenburg, Daiguan Yu, E-Chiang Lee et al. · Journal of Lipid Research · 2009 · 125 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16

1–3 of 3